Inventor · disambiguated record
Masami Yamada
Also filed as: YAMADA MASAMI
27 granted patents·7 pending applications·125 citations·filing 1996–2024
96Inventor score
Files withTAKEDA PHARMACEUTICALS CO27PEPTIDREAM INC3ISHICHI YUJI1TAKEDA PHARMACEUTICAL1TOYO INK MFG CO1
Top patents by PatentIndex Score
34 records- 0195US9878989B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jan 30, 2018·7 cites·2 claims
- 0294US9518042B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Dec 13, 2016·8 cites·2 claims
- 0394US9499516B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Nov 22, 2016·8 cites·2 claims
- 0494US9315458B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2015·Granted Apr 19, 2016·8 cites·2 claims
- 0593US10087150B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Oct 2, 2018·5 cites·2 claims
- 0692US10428056B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Oct 1, 2019·4 cites·2 claims
- 0791US11236099B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Feb 1, 2022·4 cites·22 claims
- 0891US10548899B2Quinazolinone and benzotriazinone compounds with cholinergic muscarinin M1 receptor positive allosteric modulator activityTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Feb 4, 2020·7 cites·11 claims
- 0991US9868725B2Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimer's diseaseTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jan 16, 2018·5 cites·16 claims
- 1090US10323027B22,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptorTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jun 18, 2019·4 cites·6 claims
- 1190US2024109874A1Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1286US10457670B2Isoindoline-1-one derivatives as cholinergic muscarinic M1 receptor positive alloesteric modulator activity for the treatment of Alzheimers diseaseTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Oct 29, 2019·2 cites·13 claims
- 1386US9789084B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Oct 17, 2017·2 cites·5 claims
- 1486US9789083B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Oct 17, 2017·2 cites·5 claims
- 1586US9775827B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Oct 3, 2017·2 cites·5 claims
- 1686US9675597B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jun 13, 2017·2 cites·1 claims
- 1786US9662316B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted May 30, 2017·2 cites·1 claims
- 1886US9655881B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted May 23, 2017·2 cites·1 claims
- 1985US10899752B22,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptorTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Jan 26, 2021·1 cites·11 claims
- 2084US2022411413A1Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 2182US10208046B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Feb 19, 2019·4 cites·14 claims
- 2281US9777005B2Bicyclic heterocyclic compound containing a substituted pyrrole ringTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Oct 3, 2017·5 cites·12 claims
- 2378US11407748B2Substituted pyrido[1,2-a]pyrimidines and pyrazino[1,2-a]pyrimidines for enhancing AMPA receptor functionTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Aug 9, 2022·1 cites·12 claims
- 2476US10865200B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Dec 15, 2020·0 cites·3 claims
- 2576US2021009572A1Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2020·Application pending·0 cites
- 2674US10548877B2Aromatic ring compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Feb 4, 2020·2 cites·11 claims
- 2770US6046256AAqueous dispersion compositionTOYO INK MFG CO·Filed 1996·Granted Apr 4, 2000·32 cites·4 claims
- 2869US2018000780A1Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Application pending·0 cites
- 2966US12378256B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Aug 5, 2025·0 cites·17 claims
- 3058US2024400499A1Novel amino acid derivativesPEPTIDREAM INC·Filed 2024·Application pending·0 cites
- 3156US2023257343A1Novel amino acid derivativesPEPTIDREAM INC·Filed 2023·Application pending·0 cites
- 3252US2023312479A1Novel amino acid derivativesPEPTIDREAM INC·Filed 2023·Application pending·0 cites
- 3329US8722662B2Heterocyclic compoundsISHICHI YUJI·Filed 2011·Granted May 13, 2014·0 cites·14 claims
- 3427US5939159AAqueous resin dispersionTOYO MANUFACTURING COMPANY LTD·Filed 1996·Granted Aug 17, 1999·6 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Masami Yamada files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →